Evidence map›Paper›PMID 31309353›Full record

ReviewHeart failure reviews2020

Pharmacological preconditioning with phosphodiestrase inhibitor: an answer to stem cell survival against ischemic injury through JAK/STAT signaling.

Manju Yadav, Pooja Kumari, Varsha Yadav, Sanjay Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. HOxidative medicine and cellular longevity · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Manju YadavDepartment of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India.
Pooja KumariDepartment of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India.
Varsha YadavDepartment of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India.
Sanjay KumarDepartment of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India. sanjay.kumar@ucf.edu.
Central University of Haryana · INUniversity of Central Florida · US

Funding

NIH HHS RO1 HL-087246
6 · The paper itself

Abstract

Stem cell transplantation in regenerative medicine has been widely used in various disorders including cardiovascular diseases (CVD) and emerging next-generation therapy. However, transplanted stem cell encountered ischemia/reperfusion (IR) injury which is a major challenge for stem cell survival. During the acute phase after myocardial infarction (MI) cytokine-rich hostile microenvironment, extensive immune cell infiltration and lack of oxygen have been a bottleneck in cell-based therapy. During prolonged ischemia, intracellular pH and ATP level decrease results in anaerobic metabolism and lactate accumulation. Consequentially, ATPase-dependent ion transport becomes dysfunctional, contributing to calcium overload and cell death by apoptosis and necrosis. Although O

Indexed as

Up-RegulationAnimalsApoptosisCell SurvivalHumansJanus KinasesMyocardial IschemiaMyocardiumSignal TransductionSTAT Transcription FactorsStem CellsStem Cell TransplantationJanus KinasesSTAT Transcription FactorsIschemia/reperfusionJAK-STATPhosphodiestrasePreconditioningProtein kinase G

Identifiers

PMID31309353
OpenAlexW2960389983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.